Article

Anthropic begins IPO roadshow with proposed $70–$78 share price

What Anthropic’s proposed IPO means for company funding, shareholder sales and public trading—and why deal size is not valuation.

Editorial illustration for Anthropic begins IPO roadshow with proposed $70–$78 share price: a document represents the research briefing. Not documentary evidence.

Anthropic, the company behind Claude, announced its initial public offering (IPO) roadshow on November 10, 2026, with a proposed US$70–$78 share price.

For prospective investors, a roadshow is a series of management presentations designed to gauge demand for shares. It is not the start of public trading.

Anthropic has applied to list on Nasdaq as ANT. Its notice said registration was not yet effective, so shares could not yet be sold under it. No trading-start date was confirmed.

How much could Anthropic receive?

A calculation using the announced terms puts potential company proceeds at $56.1–$62.5 billion: 801,351,354 new shares multiplied by $70–$78. This assumes all those shares sell at the range endpoints, before fees and expenses and excluding the underwriters’ option to buy more.

Existing holders’ 23,648,646 shares add about $1.66–$1.84 billion, taking the 825-million-share base offering to $57.8–$64.4 billion. That extra money goes to the sellers, not Anthropic. These are conditional gross amounts, not cash already received.

Neither figure is a company valuation. Market capitalization uses the share price and all outstanding shares, not just those in an offering. Funding, deal size and valuation answer different questions.

The proposed range is not a guaranteed buying price

There are three distinct prices to watch: the indicative range, the final offer price and the price once exchange trading begins. They need not match. The SEC’s investor guide distinguishes an IPO allocation at the offer price from buying later in the market, where prices can be higher or lower.

The next milestones to look for are registration becoming effective and a final prospectus, which normally supplies final pricing. SEC effectiveness allows an offering to proceed; it does not endorse the investment. A confirmed exchange debut is a separate milestone.

For Claude users, financing terms alone establish no change to subscriptions or service. Product access is a separate question, covered in RohitAI’s Claude 5.2 pricing and access guide.